Merck, Premier partner to tackle C. diff: 4 things to know

Premier is expanding an existing partnership with Merck to address Clostridium difficile infections in hospitals.

Here are four things to know:

1. Merck and Premier first partnered in 2016 to co-develop and test healthcare improvement solutions for specific groups of at-risk patients.

2. Under the new initiative, the companies will create a software-based platform to offer surveillance, consultation, support and education to C. diff patients, in conjunction with a care coordinator.

"The goal is to increase patient access to healthcare services, raise awareness of how to decrease patient risk of recurrence and help patients identify if they are having a recurrence," said Premier.

3. Merck and Premier will test the improvement initiative at participating Premier member health systems.

4. Financial terms of the deal were not disclosed.

More articles on clinical leadership and infection control: 
Obese hospital patients less likely to die from sepsis, study finds
Viewpoint: Why state-mandated nurse ratios could harm patient safety
Missouri heart attack patients now sent to best-equipped hospital — not always the closest

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers